ID

40873

Description

Study ID: 101468/902 Clinical Study ID: 101468/902 Study Title:A study to evaluate the effect of repeated oral doses of ropinirole on cardiac conduction as assessed by 12-lead electrocardiogram compared to placebo and single oral doses of moxifloxacin (Bayer) as a positive control. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Sponsor: GlaxoSmithKline Phase: Phase 1 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara; Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication: Restless Legs Syndrome

Mots-clés

  1. 29/05/2020 29/05/2020 -
Détendeur de droits

GlaxoSmithKline

Téléchargé le

29 mai 2020

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Effect of ropinirole on cardiac conduction as assessed by 12-lead electrocardiogram (101468/902)

Drug Tolerance; Dose Details

Administrative
Description

Administrative

Alias
UMLS CUI-1
C1320722
Subject Number
Description

Subject Number

Type de données

text

Alias
UMLS CUI [1]
C2348585
Drug Tolerance
Description

Drug Tolerance

Alias
UMLS CUI-1
C0013220
Did the patient tolerate 0.125mg/0.25mg?
Description

Did the patient tolerate 0.125mg/0.25mg?

Type de données

boolean

Alias
UMLS CUI [1]
C0013220
If patient did not tolerate the dose, enter the reason why
Description

If patient did not tolerate the dose, enter the reason why

Type de données

text

Alias
UMLS CUI [1,1]
C0013220
UMLS CUI [1,2]
C0566251
In the Investigator’s opinion, is it safe for the subject to increase to the next dose level?
Description

Y - Subject will receive the next dose level. N - Select a dosing strategy from the options below and tick the relevant box:

Type de données

boolean

Alias
UMLS CUI [1,1]
C1735338
UMLS CUI [1,2]
C1113679
If it is not safe for the subject to increase to the next dose level, select a dosing strategy from the options below and tick the relevant box:
Description

If it is not safe for the subject to increase to the next dose level, select a dosing strategy from the options below and tick the relevant box:

Type de données

integer

Alias
UMLS CUI [1,1]
C1735338
UMLS CUI [1,2]
C1113679
UMLS CUI [2,1]
C0178602
UMLS CUI [2,2]
C0679199
Dose Details
Description

Dose Details

Alias
UMLS CUI-1
C0678766
UMLS CUI-2
C1522508
Dose to be attempted:
Description

Dose to be attempted:

Type de données

integer

Unités de mesure
  • mg
Alias
UMLS CUI [1]
C3174092
mg
Dose Level Attempt:
Description

Dose Level Attempt:

Type de données

integer

Alias
UMLS CUI [1,1]
C3174092
UMLS CUI [1,2]
C0441889
Dose Details - Comments
Description

Dose Details - Comments

Type de données

text

Alias
UMLS CUI [1,1]
C0678766
UMLS CUI [1,2]
C1522508
UMLS CUI [1,3]
C0947611
Dose checked and administered by:
Description

Dose checked and administered by:

Type de données

text

Alias
UMLS CUI [1,1]
C1283174
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C2348343
Dose checked and witnessed by:
Description

Dose checked and witnessed by:

Type de données

text

Alias
UMLS CUI [1,1]
C1283174
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0682356
UMLS CUI [1,4]
C0178602

Similar models

Drug Tolerance; Dose Details

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Administrative
C1320722 (UMLS CUI-1)
Subject Number
Item
Subject Number
text
C2348585 (UMLS CUI [1])
Item Group
Drug Tolerance
C0013220 (UMLS CUI-1)
Did the patient tolerate 0.125mg/0.25mg?
Item
Did the patient tolerate 0.125mg/0.25mg?
boolean
C0013220 (UMLS CUI [1])
If patient did not tolerate the dose, enter the reason why
Item
If patient did not tolerate the dose, enter the reason why
text
C0013220 (UMLS CUI [1,1])
C0566251 (UMLS CUI [1,2])
In the Investigator’s opinion, is it safe for the subject to increase to the next dose level?
Item
In the Investigator’s opinion, is it safe for the subject to increase to the next dose level?
boolean
C1735338 (UMLS CUI [1,1])
C1113679 (UMLS CUI [1,2])
Item
If it is not safe for the subject to increase to the next dose level, select a dosing strategy from the options below and tick the relevant box:
integer
C1735338 (UMLS CUI [1,1])
C1113679 (UMLS CUI [1,2])
C0178602 (UMLS CUI [2,1])
C0679199 (UMLS CUI [2,2])
Code List
If it is not safe for the subject to increase to the next dose level, select a dosing strategy from the options below and tick the relevant box:
CL Item
Dose reduce to the dose level below (return to the previous dose level) for a further 1-4 days of dosing at the (1)
CL Item
lower dose level. (2)
CL Item
Administer domperidone to reduce adverse events. ONLY IF THIS IS A SECOND ATTEMPT AT THIS DOSE (3)
CL Item
LEVEL. (4)
CL Item
The investigator decides that the subject has reached their MTD. (5)
Item Group
Dose Details
C0678766 (UMLS CUI-1)
C1522508 (UMLS CUI-2)
Dose to be attempted:
Item
Dose to be attempted:
integer
C3174092 (UMLS CUI [1])
Dose Level Attempt:
Item
Dose Level Attempt:
integer
C3174092 (UMLS CUI [1,1])
C0441889 (UMLS CUI [1,2])
Dose Details - Comments
Item
Dose Details - Comments
text
C0678766 (UMLS CUI [1,1])
C1522508 (UMLS CUI [1,2])
C0947611 (UMLS CUI [1,3])
Dose checked and administered by:
Item
Dose checked and administered by:
text
C1283174 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C2348343 (UMLS CUI [1,3])
Dose checked and witnessed by:
Item
Dose checked and witnessed by:
text
C1283174 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0682356 (UMLS CUI [1,3])
C0178602 (UMLS CUI [1,4])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial